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1
Problem Identification and description 
of need
 In order to best provide preventative healthcare to the population, it is important for providers to be 
aware of vaccination guidelines and advocate for patient compliance to reduce morbidity and 
mortality. In the last 5 years, there have been significant changes in Tdap vaccination recommendations 
in pregnancy. 
 Prior to June 2011, the Advisory Committee on Immunizations Practices (ACIP) recommended Tdap 
vaccination to be given to women postpartum.1 Beginning June 2011, guidelines also endorsed 
vaccination during pregnancy if the woman had not received Tdap before. 1
 However, data has been found that Tdap vaccination between 27 and 36 weeks of pregnancy most 
effectively boosts IgG placental transmission to the fetus and results in longer lasting detection of 
antibody presence after birth.2,3 As a corollary, maternal vaccination during this critical time period has 
the potential to reduce risk of infant morbidity and mortality. In October 2012, ACIP guidelines changed 
to recommend vaccination between 27 and 36 weeks of every pregnancy to augment IgG placental 
transfer to the fetus, irrespective of previous vaccination status.1
 Maternal Tdap vaccination has been proven to be safe to the fetus during pregnancy and yet not all 
pregnant women receive the immunization.4
 A review of 16 States found overall Tdap vaccination rates before, during, and after pregnancy ranged 
from 38.2% to 76.6% from September 2011 to December 2011. 1 Of these states, Maine was found to have 
a vaccination rate of 66.2%. 1
 In one Tdap vaccination attitudes survey, 89% women reported they would get the Tdap vaccination 
during pregnancy if their physician advocated the immunization.5 Thus, it is important for physicians to be 
aware of the updated guidelines and to directly advocate vaccination for every pregnant woman.
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Public Health Cost & Unique Cost 
considerations in host community
 In 2014, there were 13 reported deaths related to pertussis and 8 of these were in the 
immunologically vulnerable population of infants less than 3 months old.6
 Approximately half of infants less than one year old infected with pertussis require hospitalization.2 
Of the cohort hospitalized, 23% develop pneumonia and 1.6% die.2
 It is particularly important to be cognizant of pertussis risks in Maine as the state has the second 
highest rate of pertussis in the USA with incidence of 41.9 per 100,000.6
 Per previous chart reviews performed by Dr. Robin Pritham, Medical Director at Eastern Maine 
Medical Center (EMMC) Family Medicine Center and Residency, Tdap vaccination in pregnancy 
compliance ranged 76-90% with overall 80% vaccinated between a sampling of dates between 
September 2014 to September 2015 at the family medicine outpatient clinic.
*Table data obtained from Dr. Robin Pritham, personal communication
History of EMMC Family Medicine Center and Residency Maternal Tdap Vaccination Compliance
Date Deliveries Tdap Vaccinated Offered and Declined Not Documented
Percent 
Vaccinated
January 2014-March 2014 53 42 11 0 79%
September 2014-January 2015 80 61 19 0 76%
May 2015-June 2015 32 29 3 0 90%
July 2015-September 2015 41 33 8 0 80%
Total: 206 165 41 0 80%
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Community perspective on issue & 
support for project 
 Dr. Nina Quicksell, DO PGY-2
 What is your perception of the EMMC Family Medicine Center and Residency’s compliance 
of the ACIP guideline to administer Tdap in the third trimester of pregnancy? “Most patients 
get it, the problem is getting the medical assistant staff to remember to remind us.”
 How do you think providers weigh maternal Tdap vaccination importance? “Providers are 
not considering the Tdap vaccination unless it is brought up because so many other things 
are going on, we lose focus.”
 What are the barriers to compliance with guidelines to vaccinate pregnant women with 
Tdap? “A lot of it is providers not bringing it up.”
 How are residents trained on Tdap in the third trimester of pregnancy guidelines? “Through 
rotations in OB and here [at the EMMC Family Medicine Center and Residency]; also 
through the ALSO course.”
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Community perspective on issue & 
support for project 
 Christie Brown, FNP
 How are providers trained on Tdap in the third trimester of pregnancy guidelines? “We use 
the immunization schedules posted on personal electronic devices/CDC website. Tdap in 
pregnancy training was topic of discussion around clinic when guidelines came out. 
Discussed at staff meetings.”
 Are providers reminded to vaccinate with Tdap during pregnancy? “Charts are reviewed 
by the clinical nurse manager and support staff and reminders to immunize are placed in 
the appointment summary line.”
 How do you think EMMC Family Medicine Center and Residency could improve patient 
compliance with vaccination recommendations? “Perhaps begin educating about safety 
of immunizations at prenatal screening/intake.”
 Why do you think patients refuse Tdap in pregnancy? “I think they are afraid of needles.”
 How do you respond when a pregnant patient states they do not want the vaccination? 
“Ask them to reconsider, to do independent research and come back with questions.”
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Intervention & Methodology
 Goal: To assess EMMC Family Medicine Center and Residency’s maternal Tdap vaccination rates 
and distribute an educational handout for quality improvement.
 Methodology: A data report was generated through electronic medical records (EMR) search 
utilizing the same methods of previous EMMC Family Medicine Center and Residency quality 
improvement reviews of maternal Tdap vaccination rates. To generate the number of 
pregnancies within the time frame, the EMR was searched with parameters that included women 
with an estimated due date between February 1st 2016 and August 1st 2016. To determine 
numbers of those vaccinated, a second parameter was added selecting patients who had 
documented Tdap vaccination between August 1st 2015 and August 1st 2016. Within the 
unvaccinated group, the patients with documented refusal in the EMR were classified as 
documented Tdap refusal. The remaining number of patients were placed into the 
undocumented, unvaccinated group.
 Intervention: To communicate clinic compliance rates and provide a reminder of the importance 
of maternal Tdap vaccination, I decided to create an educational handout including high-yield 
points about pertussis and this project’s data report findings (see appendix A). This handout was 
e-mailed to EMMC Family Medicine Center and Residency’s provider, resident, and clinical 
support staff listservs. Further, the handout was posted in the nursing documentation room, office 
break room, on two bulletin boards, and in physician preceptor room for total of 5 locations 




 92 eligible pregnancies discovered:
 72 (78%) were vaccinated
 8 (9%) were documented refusals
 12 (13%) were not documented as given or offered in 
the EMR
 Vaccination rates were found to be consistent with 
previous data of overall 80% compliance at sporadic 
periods of data review January 2014 to September 
2015.
 Surprisingly, there were 8 undocumented cases in the 
dates reviewed compared to no undocumented 
cases in dates previously analyzed by Dr. Robin 
Pritham.
 Educational handout developed (appendix A):
 Posted in 5 non-patient areas in the EMMC Family 
Medicine Center and Residency office
 Distributed paper copy to all resident mailboxes

















Comparison of Maternal Tdap Vaccination Rates at Various 
Time Periods
EMMC Family Medicine and Residency Tdap in Pregnancy Compliance: 








Evaluation of Effectiveness & 
Limitations
 Limitations: 
 The computerized data report could not individually pick out what week of the pregnancy the 
Tdap was given for each patient but instead assessed for vaccination during the August 2015 to 
August 2016 time frame. As a result, there is the potential that some of the numbers counted as 
vaccinated may have had it administered outside the 27 to 36 weeks recommended time period 
but otherwise during or closely around pregnancy.
 Since the search only evaluated entries on the EMR flowsheet and immunization administration 
record, undocumented numbers may have been falsely inflated due to the possibility of patients 
being vaccinated outside the EMMC system. The undocumented rate may have also been inflated 
if providers simply typed in notes that the vaccination was refused instead of adding it into the 
flowsheet.
 Evaluation of effectiveness: 
 The handout educated faculty, providers, residents, and clinical support staff of the clinic’s 
maternal Tdap administration rates, ACIP guidelines, and rationale for vaccination.
 In order to evaluate effectiveness of the handout on vaccination rates, several months would have 
to pass after project completion to accumulate an adequate sample of pregnant women. This was 
not feasible due to the time constraint of a 5-week rotation in Bangor, ME. 
 However, several providers gave positive feedback that the handout was a helpful reminder; two 
directly reported that they wanted to use the information to reach out to patients and/or clinical 
care staff.
7
Recommendations for the Future
 Documentation of Tdap refusal could be improved by scheduled, regular reminders to 
providers and clinical support staff during the weekly office huddles.
 Provider awareness of maternal Tdap vaccination compliance could be raised by 
increasing data report frequency to bimonthly and having subsequent discussions of Tdap
vaccination rates in the office huddles for each report.
 For future projects, more accurate and in-depth data could be obtained with a chart 
review to determine exactly what weeks of pregnancy patients received the Tdap
vaccination. Also, a thorough chart review could determine if there are trends based on 
training background or provider’s level of experience being associated with lower or 
higher vaccination rates.
 The office plans to add a check box to pregnancy intake forms that most providers fill out 
for each pregnancy visit. When this is completed, future projects could repeat these 
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 Thank you for agreeing to be interviewed. This project is a requirement for the Family Medicine 
clerkship. It will be stored on the Dana Library ScholarWorks website. Your name will be attached 
to your interview and you may be cited directly or indirectly in subsequent unpublished or 
published work. 
 The interviewer affirms that he/she has explained the nature and purpose of this project.
 The interviewee affirms that he/she has consented to this interview. 
 Yes __X__ 
 Name: ___Christie Brown, FNP__________________________________________




• Posted in 5 non-patient 
areas in the EMMC 
Family Medicine Center 
and Residency office
• Distributed to all resident 
mailboxes
• E-mailed out to clinic 
faculty, providers, 
residents, and clinical 
support staff
